Additional file 2 of N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer

Additional file2: Table S1: Each sample in the CESC cohort is divided into two clusters based on cluster analysis. Table S2: m6A and lncRNA genes derived from the CESC cohort. Table S3: Expression relationship between m6A and lncRNA in the CESC cohort. Table S4: Clinical characteristics of each sample in the CESC cohort. Table S5: Tumour microenvironmental characteristics of each sample in the CESC cohort. Table S6: Tumour microenvironment stromal score, immune score, and total tumour microenvironment score for each sample in the CESC cohort. Table S7: Construction of an independent prognostic model for the CESC cohort: factors and coefficients. Table S8: Survival time and survival status, lncRNA coefficient, risk score, and high/low risk classification for each sample in the CESC cohort.

附加文件2：表S1：基于聚类分析，将CESC队列中的每个样本划分为两个聚类簇。表S2：从CESC队列中获取的N6-甲基腺嘌呤（m6A）相关基因与长链非编码RNA（long non-coding RNA, lncRNA）基因。表S3：CESC队列中N6-甲基腺嘌呤（m6A）相关基因与长链非编码RNA的表达关联情况。表S4：CESC队列中每个样本的临床特征信息。表S5：CESC队列中每个样本的肿瘤微环境特征。表S6：CESC队列中每个样本的肿瘤微环境基质评分、免疫评分及肿瘤微环境总评分。表S7：CESC队列独立预后模型的构建：影响因子及其系数。表S8：CESC队列中每个样本的生存时间、生存状态、长链非编码RNA系数、风险评分以及高低风险分组结果。